🦊/Companies

Kailos Genetics

Huntsville, US · Founded 2010 · Delaware corporation · 2 known investors

Find your way into Kailos Genetics

351 people in our graph share verified history with the Kailos Genetics team — schools, employers, funds. One of them is your warm intro.

Diana Berishaunlockedknows Ogan Abaan · together at Georgetown (overlapped)
×6knows the team · via Georgetown
×3knows the team · via Orta Doğu Teknik Üniversitesi / Middle East Technical University
×2knows the team · via Invitrogen

Kailos Genetics is a biotechnology company with expertise in medical and biotechnology industries.

Founders & leadership

RC
Randall C. BachmeyerExecutive
BK
Brian K. PollockinCo-founder and CEO2010–2025Brian Pollock co-founded Kailos Genetics, a molecular diagnostic company, which he led as CEO for 15 years; previously he co-founded and served as CEO of Open Biosystems through its acquisition by Thermo Fisher Scientific, and held senior roles at Invitrogen and Research Genetics in genomics.
CLCheri L. Walker
Cheri L. WalkerinExecutive
OA
Ogan AbaaninVice President of Lab OperationsHe brings 15+ years of experience in precision medicine and genomics, including work on large-scale sequencing initiatives, government contracting programs, and next-generation sequencing applications.
DT
David Troy MooreNamed on SEC filing
RM
Ron McGlennenMedical Director
DK
David KloskeDirector of Bioinformatics

Board

JR
James R. Hudson, Jr.Board director
KT
Katherine T. VarleyBoard director
DW
Danny WindhamBoard director
MJ
Michael J. WaltersBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$2M disclosed across 1 of 4 rounds · 2014–2018

$2MraisedApr 2018 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael J. WaltersDirector
  • Danny WindhamDirector
  • David Troy MooreExecutive Officer, Director
  • Brian K. PollockExecutive Officer, Director
  • Randall C. BachmeyerExecutive Officer
  • Cheri WalkerExecutive Officer
  • James R. Hudson, Jr.Director
  • Katherine T. VarleyDirector
Offering amount
$2M
Amount sold
$2M
First sale
Feb 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2MofferedNov 2016 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael J. WaltersDirector
  • Katherine T. VarleyDirector
  • Randall C. BachmeyerExecutive Officer
  • David Troy MooreExecutive Officer, Director
  • Brian K. PollockExecutive Officer, Director
Offering amount
$2M
Minimum investment
$25K
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$4MofferedAug 2015 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Katherine T. VarleyDirector
  • Randall C. BachmeyerExecutive Officer
  • Brian K. PollockExecutive Officer, Director
  • James R. Hudson, Jr.Director
  • Danny WindhamDirector
  • David Troy MooreExecutive Officer, Director
  • Michael J. WaltersDirector
  • Cheri L. WalkerExecutive Officer
Offering amount
$4M
Minimum investment
$100K
Proceeds to insiders
$180K
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.5MofferedJul 2014 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David Troy MooreExecutive Officer, Director
  • Michael J WaltersExecutive Officer, Director
  • Randall C BachmeyerExecutive Officer
  • James R. Hudson, Jr.Director
  • Danny WindhamDirector
  • Katherine T VarleyDirector
  • Brian PollockExecutive Officer, Director
Offering amount
$2.5M
Minimum investment
$100K
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Kailos Genetics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Kailos Genetics do?
Kailos Genetics is a biotechnology company with expertise in medical and biotechnology industries.
Who are Kailos Genetics's investors?
Kailos Genetics's investors include New Capital Partners, In-Q-Tel.
How much funding has Kailos Genetics raised?
Kailos Genetics has disclosed $2M raised across 1 of its 4 known rounds.
Where is Kailos Genetics headquartered?
Kailos Genetics is headquartered in Huntsville, US.